Ronellenfitsch MW - Search Results

1

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.

Herrlinger U, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Maciaczyk J, Grau S, Schnell O, Hänel M, Krex D, Vajkoczy P, Gerlach R, Kortmann RD, Mehdorn M, Tüttenberg J, Mayer-Steinacker R, Fietkau R, Brehmer S, Mack F, Stuplich M, Kebir S, Kohnen R, Dunkl E, Leutgeb B, Proescholdt M, Pietsch T, Urbach H, Belka C, Stummer W, Glas M. Herrlinger U, et al. Among authors: ronellenfitsch mw. J Clin Oncol. 2016 May 10;34(14):1611-9. doi: 10.1200/JCO.2015.63.4691. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976423 Clinical Trial.

2

Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?

Rieger J, Bähr O, Ronellenfitsch MW, Steinbach J, Hattingen E. Rieger J, et al. Among authors: ronellenfitsch mw. J Clin Oncol. 2010 Sep 20;28(27):e477; author reply e478. doi: 10.1200/JCO.2010.29.2029. Epub 2010 Jun 28. J Clin Oncol. 2010. PMID: 20585096 No abstract available.

3

The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma.

Voss V, Senft C, Lang V, Ronellenfitsch MW, Steinbach JP, Seifert V, Kögel D. Voss V, et al. Among authors: ronellenfitsch mw. Mol Cancer Res. 2010 Jul;8(7):1002-16. doi: 10.1158/1541-7786.MCR-09-0562. Epub 2010 Jun 29. Mol Cancer Res. 2010. PMID: 20587533

4

Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives.

Ronellenfitsch MW, Steinbach JP, Wick W. Ronellenfitsch MW, et al. Target Oncol. 2010 Sep;5(3):183-91. doi: 10.1007/s11523-010-0154-5. Epub 2010 Sep 19. Target Oncol. 2010. PMID: 20853178 Review.

5

PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.

Burger MC, Brucker DP, Baumgarten P, Ronellenfitsch MW, Wanka C, Hasselblatt M, Eccles MR, Klingebiel T, Weller M, Rieger J, Mittelbronn M, Steinbach JP. Burger MC, et al. Among authors: ronellenfitsch mw. Int J Oncol. 2012 Jul;41(1):235-41. doi: 10.3892/ijo.2012.1446. Epub 2012 Apr 25. Int J Oncol. 2012. PMID: 22552444 Free article.

6

Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.

Fischer S, Ronellenfitsch MW, Thiepold AL, Harter PN, Reichert S, Kögel D, Paschke R, Mittelbronn M, Weller M, Steinbach JP, Fulda S, Bähr O. Fischer S, et al. Among authors: ronellenfitsch mw. PLoS One. 2014 Apr 17;9(4):e94921. doi: 10.1371/journal.pone.0094921. eCollection 2014. PLoS One. 2014. PMID: 24743710 Free PMC article.

7

Sustained focal antitumor activity of bevacizumab in recurrent glioblastoma.

Bähr O, Harter PN, Weise LM, You SJ, Mittelbronn M, Ronellenfitsch MW, Rieger J, Steinbach JP, Hattingen E. Bähr O, et al. Among authors: ronellenfitsch mw. Neurology. 2014 Jul 15;83(3):227-34. doi: 10.1212/WNL.0000000000000594. Epub 2014 Jun 13. Neurology. 2014. PMID: 24928118

8

Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition.

Hartel I, Ronellenfitsch M, Wanka C, Wolking S, Steinbach JP, Rieger J. Hartel I, et al. Int J Oncol. 2016 Jul;49(1):173-80. doi: 10.3892/ijo.2016.3498. Epub 2016 Apr 25. Int J Oncol. 2016. PMID: 27121290

9

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.

Steidl E, Pilatus U, Hattingen E, Steinbach JP, Zanella F, Ronellenfitsch MW, Bähr O. Steidl E, et al. Among authors: ronellenfitsch mw. PLoS One. 2016 Dec 29;11(12):e0168113. doi: 10.1371/journal.pone.0168113. eCollection 2016. PLoS One. 2016. PMID: 28033329 Free PMC article.

10

Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.

Wenger KJ, Wagner M, You SJ, Franz K, Harter PN, Burger MC, Voss M, Ronellenfitsch MW, Fokas E, Steinbach JP, Bähr O. Wenger KJ, et al. Among authors: ronellenfitsch mw. Oncol Lett. 2017 Jul;14(1):1141-1146. doi: 10.3892/ol.2017.6251. Epub 2017 May 25. Oncol Lett. 2017. PMID: 28693286 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page